The Thompson Investment Management Inc holds 272,661 shares with $12.85M value, down from 299,239 last quarter. Anthem Inc now has $59.53 billion valuation. The stock increased 1.94% or $0.985 during the last trading session, reaching $51.775. About 360,465 shares traded. It has outperformed by 441.54% the S&P500. About 1.44M shares traded or 220.17% up from the average. Its down 7.6% from 214,600 shares previously. With 88,500 avg volume, 8 days are for Pldt Inc Sponsored Adr (NYSE:PHI)'s short sellers to cover PHI's short positions. Eagle Asset Management Inc reported 160,482 shares or 0.03% of all its holdings. IRIDEX Corporation (NASDAQ:IRIX) has declined 35.41% since March 7, 2017 and is downtrending. It has underperformed by 1.65% the S&P500. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders.
Investors sentiment increased to 1.24 in 2017 Q3. Its up 0.65, from 0.55 in 2017Q2. It is positive, as 42 investors sold RTN shares while 343 reduced holdings. 22 funds opened positions while 77 raised stakes. Eulav Asset Mngmt accumulated 0.48% or 215,000 shares. Antipodean Advisors Llc bought 101,000 shares as the company's stock rose 53.09% with the market. Lyon Street Ltd invested 1.6% of its portfolio in IRIDEX Corporation (NASDAQ:IRIX). Amer Ins Tx holds 0.41% or 165,120 shares. Perkins Cap invested 0.87% of its portfolio in IRIDEX Corporation (NASDAQ:IRIX). Moreover, Tensile Capital Management Llc has 3.63% invested in the company for 500,101 shares. Utd Services Automobile Association reported 236,430 shares. Huntington Fincl Bank has 1,023 shares. The fund owned 15,475 shares of the medical research company's stock after selling 10,825 shares during the quarter. Riverhead Mgmt Ltd reported 0.07% stake. Northern Trust owns 1.48M shares.
Among 9 analysts covering Spx Flow Inc (NYSE:FLOW), 4 have Buy rating, 2 Sell and 3 Hold.More news: SBI slashes minimum balance non-maintenance fines by up to 75%
Ratings analysis reveals 33% of Progress Software's analysts are positive. Raytheon Company had 76 analyst reports since July 28, 2015 according to SRatingsIntel. Wedbush maintained Progress Software Corporation (NASDAQ:PRGS) on Wednesday, January 18 with "Neutral" rating. The rating was maintained by Roth Capital on Sunday, February 25 with "Buy". The company's Market capitalization is $5.73B with the total Outstanding Shares of "Outstanding".
Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.13, from 1.01 in 2017Q2. It worsened, as 39 investors sold EXAS shares while 81 reduced holdings. Citadel Advsrs Limited Liability Company reported 0.01% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). The original version of this piece can be read at https://www.thelincolnianonline.com/2018/03/09/pegasus-partners-ltd-trims-stake-in-exact-sciences-co-exas.html. Perigon Wealth Limited Liability Com, a California-based fund reported 30 shares. Ahl Partners Llp invested in 0.01% or 8,743 shares. Jpmorgan Chase And Co stated it has 0.03% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). Victory Mgmt Incorporated has invested 0% of its portfolio in Hudson Pacific Properties, Inc. Susquehanna Intll Gp Limited Liability Partnership holds 5,596 shares. Rhumbline Advisers owns 0.01% invested in Exact Sciences Corporation (NASDAQ:EXAS) for 140,967 shares. Eventide Asset Management Llc owns 100,000 shares or 0.27% of their U.S. portfolio. Philippine Long Distance Telephone had 7 analyst reports since August 5, 2015 according to SRatingsIntel. The average analysts gave this company a mean recommendation of 2.00. Zweig reported 1.82% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS).
Since September 29, 2017, it had 0 buys, and 14 insider sales for $27.28 million activity. $126,252 worth of Exact Sciences Corporation (NASDAQ:EXAS) shares were sold by Elliott Jeffrey Thomas. Shares for $243,068 were sold by ARORA MANEESH on Monday, February 26.More news: Warren Buffett Offers Big Money for Bracket Challenge
Exact Sciences Corporation (EXAS) shares jumped 3.04 percent and closed the day at $49.21. Shares for $87,474 were sold by COWARD D SCOTT. Therefore 56% are positive. On Tuesday, October 6 the stock rating was maintained by Roth Capital with "Buy". The stock has "Buy" rating by Craig Hallum on Thursday, July 6. The stock has "Equal-Weight" rating by Stephens on Thursday, February 25. The stock of Exact Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by Jefferies on Tuesday, July 4. The rating was maintained by Leerink Swann with "Buy" on Monday, November 13. The company has a consensus rating of Buy and an average target price of $52.84. The firm has "Buy" rating by Cowen & Co given on Wednesday, May 31. Leerink Swann has "Outperform" rating and $63 target.
EXACT Sciences (NASDAQ:EXAS) announced its quarterly earnings results on Thursday, February 22nd. The rating was upgraded by Benchmark to "Buy" on Tuesday, February 21. BTIG Research has "Buy" rating and $4500 target. Bank of America increased their price target on shares of EXACT Sciences from $58.00 to $67.00 and gave the stock a "buy" rating in a report on Wednesday, November 29th.
Ads (NASDAQ:GDS) had a decrease of 17.05% in short interest. It also upped Express Sc (NASDAQ:ESRX) stake by 7,442 shares and now owns 21,112 shares. Acelrx Pharmaceuticals Inc (NASDAQ:ACRX) was reduced too.More news: Oil prices move lower after Friday's rig-powered surge
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.